Amylx Pharmaceuticals Inc vs Seagate Technology Holdings PLC — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Seagate Technology Holdings PLC trades at $842.99 (market cap $185.97B). The key difference: Seagate Technology Holdings PLC is far larger — about 70.4× Amylx Pharmaceuticals Inc's market cap, and Seagate Technology Holdings PLC pays a 0.36% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | STX | |
|---|---|---|
Market Cap | $2.64B | $185.97B |
Sector | Health | Technology |
52-Week High | $24.19 | $1.09K |
52-Week Low | $7.82 | $154.43 |
Enterprise Value | $2.39B | $188.12B |
Dividend Yield | — | 0.36% |
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →Seagate is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital
Read more on STX →